A taurolidine-based antimicrobial catheter lock solution with urokinase, designed to support infection prevention and thrombolytic vascular catheter management.
Designed in collaboration with cardiologists to solve the most common challenges in radial hemostasis.
Eradicates and prevents catheter biofilm formation.
Associated with reduced catheter infection risk.
Supports catheter patency and helps reduce occlusions
TauroLock™-U25.000 combines taurolidine, citrate and urokinase to provide antimicrobial protection alongside thrombolytic activity. The combination is designed to help reduce microbial contamination and support catheter patency by addressing both infection risk and fibrin-related catheter occlusion.
Speak to our team for more information, product details or support with your enquiry.
There is no information to display.
There is no information to display.
